71 phenotypes from 12 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cdh5tm1.1Ics/Cdh5tm1.1Ics B6.129(Cg)-Cdh5tm1.1Ics	abnormal ovary morphology	J:214298
	abnormal uterus morphology	J:214298
	abnormal vascular endothelial cell morphology	J:214298
	edema	J:214298
	enlarged endometrial glands	J:214298
	enlarged ovary	J:214298
	enlarged uterus	J:214298
	increased vascular permeability	J:214298
	ovarian follicular cyst	J:214298
	ovary cyst	J:214298
	ovary fibrosis	J:214298
	uterus fibrosis	J:214298
	uterus hypertrophy	J:214298
Cdh5tm1.1Pec/Cdh5tm1.1Pec Not Specified	abnormal angiogenesis	J:56509
	abnormal cardiac outflow tract development	J:56509
	abnormal intersomitic vessel morphology	J:56509
	abnormal placenta vasculature	J:56509
	abnormal somite development	J:56509
	abnormal vascular development	J:56509
	abnormal vascular endothelial cell development	J:56509
	abnormal vasculogenesis	J:56509
	abnormal vein development	J:56509
	abnormal vitelline vasculature morphology	J:56509
	delayed heart development	J:56509
	embryonic growth arrest	J:56509
	embryonic lethality during organogenesis, complete penetrance	J:56509
	normal hematopoietic system phenotype	J:56509
	increased apoptosis	J:56509
	small pharyngeal arch	J:56509
Cdh5tm1Dvst/Cdh5tm1Dvst Tg(Cdh5-cre/ERT2)1Rha/0 Not Specified	abnormal retina vasculature morphology	J:189010
Cdh5tm1Dvst/Cdh5tm1Dvst Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0 involves: C57BL/6 * CBA	abnormal retina development	J:328283
	decreased angiogenesis	J:328283
	hemorrhage	J:328283
	increased angiogenesis	J:328283
Cdh5tm1Hub/Cdh5tm1Hub involves: 129S1/Sv * 129X1/SvJ	abnormal vasculogenesis	J:98466
Cdh5tm1Hub/Cdh5tm1Hub involves: 129S1/Sv * 129X1/SvJ * BALB/cIco	abnormal cell death	J:54177
	abnormal intersomitic vessel morphology	J:54177
	abnormal umbilical artery morphology	J:54177
	abnormal umbilical cord blood vessel morphology	J:54177
	abnormal vasculogenesis	J:54177
	abnormal visceral yolk sac blood island morphology	J:54177
	absent vitelline blood vessels	J:54177
	decreased angiogenesis	J:54177
	dilated dorsal aorta	J:54177
	distended pericardium	J:54177
	embryonic growth retardation	J:54177
	embryonic lethality during organogenesis, complete penetrance	J:54177
	incomplete embryo turning	J:54177
	incomplete somite formation	J:54177
	irregular heartbeat	J:54177
	pallor	J:54177
Cdh5tm1Pec/Cdh5tm1Pec Not Specified	abnormal angiogenesis	J:56509
	abnormal cardiac outflow tract development	J:56509
	abnormal intersomitic vessel morphology	J:56509
	abnormal placenta vasculature	J:56509
	abnormal somite development	J:56509
	abnormal vascular development	J:56509
	abnormal vascular endothelial cell development	J:56509
	abnormal vasculogenesis	J:56509
	abnormal vein development	J:56509
	abnormal vitelline vasculature morphology	J:56509
	delayed heart development	J:56509
	embryonic growth arrest	J:56509
	embryonic lethality during organogenesis, complete penetrance	J:56509
	normal hematopoietic system phenotype	J:56509
	increased apoptosis	J:56509
	small pharyngeal arch	J:56509
Cdh5tm2(Cdh5)Dvst/Cdh5tm2(Cdh5)Dvst involves: 129 * C57BL/6	no abnormal phenotype detected	J:177191
Cdh5tm2Pec/Cdh5tm2Pec Not Specified	abnormal angiogenesis	J:56509
	abnormal cardiac outflow tract development	J:56509
	abnormal intersomitic vessel morphology	J:56509
	abnormal placenta vasculature	J:56509
	abnormal somite development	J:56509
	abnormal vascular development	J:56509
	abnormal vascular endothelial cell development	J:56509
	abnormal vasculogenesis	J:56509
	abnormal vein development	J:56509
	abnormal vitelline vasculature morphology	J:56509
	delayed heart development	J:56509
	embryonic growth arrest	J:56509
	embryonic lethality during organogenesis, complete penetrance	J:56509
	normal hematopoietic system phenotype	J:56509
	increased apoptosis	J:56509
	small pharyngeal arch	J:56509
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst B6.Cg-Cdh5tm3(Cdh5/Ctnna1)Dvst	abnormal common myeloid progenitor cell morphology	J:213676
	abnormal definitive hematopoiesis	J:213676
	abnormal hematopoietic stem cell physiology	J:213676
	abnormal lymphatic vessel endothelium morphology	J:213676
	abnormal lymphatic vessel morphology	J:213676
	normal cardiovascular system phenotype	J:213676
	decreased liver weight	J:213676
	embryonic lethality during organogenesis, incomplete penetrance	J:213676
	embryonic lethality, complete penetrance	J:177191
	increased hematopoietic precursor cell number	J:213676
	lethality throughout fetal growth and development, complete penetrance	J:213676
	liver hypoplasia	J:213676
	lymphedema	J:213676
	small liver	J:213676
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst involves: 129 * C57BL/6	abnormal cellular extravasation	J:177191
	abnormal leukocyte migration	J:177191
	abnormal lymphatic vessel endothelial cell morphology	J:213676
	abnormal skin physiology	J:177191
	abnormal vascular permeability	J:177191
	normal immune system phenotype	J:213676
	increased leukocyte cell number	J:177191
	increased neutrophil cell number	J:177191
	preweaning lethality, incomplete penetrance	J:177191
Cdh5tm5Dvst/Cdh5tm5Dvst B6.Cg-Cdh5tm5Dvst	abnormal cellular extravasation	J:209801
Cdh5tm6Dvst/Cdh5tm6Dvst B6.Cg-Cdh5tm6Dvst	abnormal cellular extravasation	J:209801
Cdh5tm7Dvst/Cdh5tm7Dvst Not Specified	embryonic lethality during organogenesis, complete penetrance	J:213676
Cdh5tm8Dvst/Cdh5tm8Dvst Commd10Tg(Vav1-icre)A2Kio/Commd10+ involves: C57BL/10 * CBA/Ca	normal liver/biliary system phenotype	J:213676